Anna-Karin Haylock
Läkare vid Institutionen för kirurgiska vetenskaper; Öron-, näs- och halssjukdomar
- E-post:
- anna-karin.haylock@uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 78/79
751 85 Uppsala - Postadress:
- Akademiska sjukhuset, ingång 78/79
751 85 Uppsala
- Akademiska meriter:
- MD, PhD
Publikationer
Senaste publikationer
-
Ingår i Clinical Nutrition ESPEN, s. 149-155, 2020
- DOI för Mapping impact factors leading to the GLIM diagnosis of malnutrition in patients with head and neck cancer
- Ladda ner fulltext (pdf) av Mapping impact factors leading to the GLIM diagnosis of malnutrition in patients with head and neck cancer
-
Ingår i International Journal of Oncology, s. 1875-1885, 2018
- DOI för Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy
- Ladda ner fulltext (pdf) av Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy
-
Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers
Ingår i Oncotarget, s. 65152-65170, 2017
- DOI för Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers
- Ladda ner fulltext (pdf) av Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers
-
Targeting molecules for diagnostics of Head and Neck squamous cell carcinoma
2017
-
A real-time in vitro assay as a potential predictor of in vivo tumor imaging properties
Ingår i Nuclear Medicine and Biology, s. 12-18, 2016
Alla publikationer
Artiklar i tidskrift
-
Ingår i Clinical Nutrition ESPEN, s. 149-155, 2020
- DOI för Mapping impact factors leading to the GLIM diagnosis of malnutrition in patients with head and neck cancer
- Ladda ner fulltext (pdf) av Mapping impact factors leading to the GLIM diagnosis of malnutrition in patients with head and neck cancer
-
Ingår i International Journal of Oncology, s. 1875-1885, 2018
- DOI för Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy
- Ladda ner fulltext (pdf) av Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy
-
Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers
Ingår i Oncotarget, s. 65152-65170, 2017
- DOI för Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers
- Ladda ner fulltext (pdf) av Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers
-
A real-time in vitro assay as a potential predictor of in vivo tumor imaging properties
Ingår i Nuclear Medicine and Biology, s. 12-18, 2016
-
Ingår i International journal of oncology, s. 461-470, 2016
- DOI för Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma
- Ladda ner fulltext (pdf) av Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma
-
A real-time in vitro assay as a potential predictor of in vivo tumour imaging properties
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2015
-
Ingår i EJNMMI Research, 2014
- DOI för In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study
- Ladda ner fulltext (pdf) av In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study
-
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2014
-
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2014
-
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2013
-
A novel CD44v6 targeting antibody fragment with improved tumor-to-blood ratio
Ingår i International Journal of Oncology, s. 1525-1532, 2012
-
Ingår i Cancer Biotherapy and Radiopharmaceuticals, s. 593-601, 2011